TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Otsuka Pharma Scandinavia AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
334,858
|
321,713
|
285,068 |
Financial expenses |
3
|
37
|
205 |
Earnings before taxes |
9,111
|
11,773
|
9,227 |
EBITDA |
8,874
|
12,142
|
9,885 |
Total assets |
131,928
|
121,328
|
103,287 |
Current assets |
131,244
|
120,822
|
102,736 |
Current liabilities |
82,913
|
70,108
|
53,933 |
Equity capital |
49,015
|
51,220
|
49,354 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
38
|
35
|
36 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
37.2%
|
42.2%
|
47.8% |
Turnover per employee |
8,812
|
9,192
|
7,919 |
Profit as a percentage of turnover |
2.7%
|
3.7%
|
3.2% |
Return on assets (ROA) |
6.9%
|
9.7%
|
9.1% |
Current ratio |
158.3%
|
172.3%
|
190.5% |
Return on equity (ROE) |
18.6%
|
23.0%
|
18.7% |
Change turnover |
13,145
|
36,645
|
-13,695 |
Change turnover % |
4%
|
13%
|
-5% |
Chg. No. of employees |
3
|
-1
|
-6 |
Chg. No. of employees % |
9%
|
-3%
|
-14% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.